Earlier this week, Bayer Health Care broadened its commitment to reproductive health supplies for women by reducing the price of its five-year contraceptive implant product, Jadelle©. The price will decrease from $21 to $19.50 per implant, and could further reduce with future large orders.
Bayer projects that with these cost savings, over half a million women who view Jadelle© as their contraceptive method of choice will now be able to access it. Potential outcomes are powerful and plentiful, including the prevention of more than 550,000 unwanted pregnancies, 255,000 abortions, 1,000 maternal deaths, and 6,000 newborn deaths.
As a member of the Reproductive Health Supplies Coalition’s HANDtoHAND Campaign, this commitment forwards the campaign’s mission to globally increase the number of users of modern contraceptive methods to 100 million by 2015. With cost reductions and more women accessing long-term contraceptive methods, fulfilling the contraceptive needs of women in low- and middle-income countries is now within reach.
Women Deliver congratulates Bayer on this commitment and partnership to better reach the 215 million women worldwide with an unmet need for family planning.
Read the announcement from John Skibiak at the Reproductive Health Supplies Coalition here.